What is Zymeworks's research and development expense?

Zymeworks (ZYME) reported research and development expense of $34.46M in Q1 2026.

How has Zymeworks's research and development expense changed year-over-year?

Zymeworks's research and development expense decreased by 3.6% year-over-year, from $35.74M to $34.46M.

What is the long-term trend for Zymeworks's research and development expense?

Over 3 years (2022 to 2025), Zymeworks's research and development expense has grown at a -13.1% compound annual growth rate (CAGR), from $208.6M to $137M.

Zymeworks ZYME Research and development expense

Research and development expense at other companies

PfizerPFE

——

AmgenAMGN

——

AnaptysBio, Inc.ANAB

——

Viridian Therapeutics, Inc.VRDN

——

Spyre Therapeutics, Inc.SYRE

——

TEC

Bio-TechneTECH

——

Segments

By product

See full

Expense for other preclinical and research programs$7.26M+19.6%

ZW191$3.03M+77.7%

ZW251$1.91M-51.7%

ZW171$1.15M-48.4%

Zanidatamab$623K-55.6%

ZW220$97K-95.6%

By segment

See full

Reportable Segment$34.46M-3.6%

Other financials

Income statement

See full

Revenue$2.4M-91.1%

Operating income-$47.1M-84.0%

Net income-$44.2M-95.1%

EPS (diluted)-$0.59-96.7%

Balance sheet

See full

Cash & equivalents$244.3M+221%

Total debt$17.0M-7.7%

Total equity$163.6M-49.7%

Total assets$478.2M+12.4%

Cash flow

See full

Operating cash flow-$45.7M-1,242%

CapEx$216.0K+1,250%

Free cash flow-$45.9M-1,242%

Valuation

See full

Market cap$1.79B+125%

Profitability

See full

Operating margin-140.4%+7.3pp

Net margin-126.3%+5.0pp

FCF margin-94.8%+15.5pp

Returns & leverage

See full

Return on equity-42%+29.2pp

Debt / equity0.1×0.0×

Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Zymeworks's research and development expense?: Zymeworks (ZYME) reported research and development expense of $34.46M in Q1 2026.
How has Zymeworks's research and development expense changed year-over-year?: Zymeworks's research and development expense decreased by 3.6% year-over-year, from $35.74M to $34.46M.
What is the long-term trend for Zymeworks's research and development expense?: Over 3 years (2022 to 2025), Zymeworks's research and development expense has grown at a -13.1% compound annual growth rate (CAGR), from $208.6M to $137M.